Market Overview

Intuitive Surgical Sees Q1 Sales Well Below Analyst Estimate, Shares Nosedive

Related ISRG
Vetr Downgrades Intuitive Surgical
Intuitive Surgical Upbeat On Q4 And 2017 Sales Results
Intuitive Surgical Just Within Buy Range As Quarterly Report Nears (Investor's Business Daily)

Shares of Intuitive Surgical (NASDAQ: ISRG) are down 12.4 percent to $425 in post-market action Tuesday as the company issued concerning preliminary first-quarter results.

Intuitive said it is anticipating revenue of $465 million, much lower than the current analyst consensus estimate of $537.9 million. The figure implies a 24 percent year-over-year decline in sales.

The revenue reflects a $26 million deferral associated with a customer trade-out program for the newly launched da Vinci Xi Surgical System. Excluding the impact of the trade-out program, revenue would have been $491 million, a decrease of 20 percent compared with the prior year.

The Company announced a pre-tax charge of $67 million to reflect estimated costs of settling a number of product liability legal claims related to alleged complications from surgeries performed with certain versions of Monopolar Curved Scissors instruments.

Posted-In: News Guidance Hot Movers


Related Articles (ISRG)

View Comments and Join the Discussion!